Affluent Medical S.A.

    Affluent Medical S.A.

    EEURONEXT:AFME
    3.20
    EUR
    -0.29
    (-8.31%)
    2016 Y
    2017 Y
    2018 Y
    2019 Y
    2020 Y
    2021 Y
    2022 Y
    2023 Y
    2024 Y
    Revenue per Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    0.11
    Basic EPS, GAAP
    -0.48
    -0.72
    - -
    -1.36
    -1.18
    -0.88
    -0.81
    -0.51
    -0.38
    Free Cash Flow per Basic Share
    - -
    -0.91
    - -
    -0.95
    -0.76
    -0.75
    -0.59
    -0.4
    -0.29
    Dividend per Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Book Value per Share
    0.82
    0.98
    - -
    -1.37
    -2.25
    -2.2
    -2.64
    -1.78
    -1.71
    Tangible Book Value per Share
    0.09
    0.32
    - -
    -2.11
    -1.6
    -0.55
    -0.91
    -0.57
    -0.44
    Basic Weighted Avg Shares
    12
    12
    - -
    12
    12
    17
    19
    31
    39
    Sales/Revenue/Turnover
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    4
    Operating Margin (%)
    -236,300
    -24,090.7
    - -
    - -
    - -
    - -
    - -
    - -
    -355.44
    Depreciation Expense
    - -
    - -
    - -
    2
    2
    2
    2
    2
    2
    Net Income, GAAP
    -6
    -9
    - -
    -17
    -14
    -15
    -15
    -16
    -15
    Effective Tax Rate (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Profit Margin (%)
    -194,566.67
    -20,353.49
    - -
    - -
    - -
    - -
    - -
    - -
    -357.92
    Working Capital
    1
    7
    - -
    -3
    -2
    7
    -1
    -3
    3
    LT Debt
    - -
    3
    11
    21
    17
    17
    16
    15
    15
    Total Equity
    59
    61
    47
    31
    35
    44
    34
    32
    30
    Return on Invested Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Common Equity (%)
    - -
    -79.8
    - -
    - -
    - -
    - -
    - -
    - -
    - -

    Capital Structure

    EUR

    •

    in mil. unless spec.
    No data availableFinancial data will appear here once available

    Working Capital

    EUR

    •

    in mil. unless spec.
    No data availableFinancial data will appear here once available

    Growth Rates

    EUR

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    - -
    0.85%
    -3.98%
    Free Cash Flow
    - -
    1.63%
    -6.27%
    Net Income, GAAP
    - -
    -2.09%
    -5.84%
    Sales/Revenue/Turnover
    - -
    - -
    - -
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    EUR

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    4
    2025
    - -
    - -
    - -
    - -
    - -

    Quarterly Earnings Per Share

    EUR

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    - -
    - -
    - -
    - -
    -0.51
    2024
    - -
    - -
    - -
    - -
    -0.38
    2025
    - -
    - -
    - -
    - -
    - -

    Quarterly Dividends Per Share

    EUR

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    - -
    2025
    - -
    - -
    - -
    - -
    - -

    Company Description

    Address
    Similar Companies
    Business